Industry
Elon Musk alleges “oligarch” interference in Starlink’s India launch
Supreme Court to examine plea that systemic blind spots in aviation boom left disabled travellers stranded
Foreign airlines grouping urges for alternatives to flight cuts at Mumbai airport
CDK Global appoints Sudhakar Ramakrishna CEO
Lupin launches fixed dose triple combo inhaler for COPD in India
Granules eyes first to file status, 180 days exclusivity on generic cancer drug Ruxolitinib in U.S.
The Hindu - Industry·7 Oct 2026
The Paragraph IV certification sought is with respect to applicable patents listed in the U.S. FDA’s Orange Book. Granules said it has also issued the requisite notice to the relevant parties in…
More news in Industry
Elon Musk alleges “oligarch” interference in Starlink’s India launchSupreme Court to examine plea that systemic blind spots in aviation boom left disabled travellers strandedForeign airlines grouping urges for alternatives to flight cuts at Mumbai airportCDK Global appoints Sudhakar Ramakrishna CEOLupin launches fixed dose triple combo inhaler for COPD in India